$3.09 - AVIR | Atea Pharmaceuticals, Inc. Common Stock

Atea Pharmaceuticals, Inc. Common Stock (AVIR)

Atea Pharmaceuticals, Inc. Common Stock

XNAS:AVIR

3.09

-0.32%

Ask

$4.27 - 100.00

Bid

$2.60 - 101.00

Low

$3.05

High

$3.1

Open

$3.07

Prev Close

$3.1

52W High

4.02

52W Low

2.46

Volume

258506

Avg Vol (3m)

381556

Float

62364405.59

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 10/30/2020

Primary Exchange: XNAS

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Phone: 857-204-8109

Address: 225 Franklin Street

Address 2: Suite 2100

City: Boston

State: MA

Postal Code: 02110

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-1.740000

P/B (TTM)

0.764494

EPS

-0.53

Round Lot

100

Composit FIGI

BBG00TZNCJ75

Share Class FIGI

BBG00TZNCJ84

Share Class Shares Outstanding

79.36M

Weighted Shares Outstanding

79.36M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion